171 related articles for article (PubMed ID: 30243024)
21. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
Zhou J; Yu Q; Zou T
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
[TBL] [Abstract][Full Text] [Related]
22. No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain.
Ingelsson M; Ramasamy K; Cantuti-Castelvetri I; Skoglund L; Matsui T; Orne J; Kowa H; Raju S; Vanderburg CR; Augustinack JC; de Silva R; Lees AJ; Lannfelt L; Growdon JH; Frosch MP; Standaert DG; Irizarry MC; Hyman BT
Acta Neuropathol; 2006 Oct; 112(4):439-49. PubMed ID: 16802167
[TBL] [Abstract][Full Text] [Related]
23. SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy.
Min SW; Sohn PD; Li Y; Devidze N; Johnson JR; Krogan NJ; Masliah E; Mok SA; Gestwicki JE; Gan L
J Neurosci; 2018 Apr; 38(15):3680-3688. PubMed ID: 29540553
[TBL] [Abstract][Full Text] [Related]
24. SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy.
Muñiz JA; Facal CL; Urrutia L; Clerici-Delville R; Damianich A; Ferrario JE; Falasco G; Avale ME
Front Bioeng Biotechnol; 2022; 10():951384. PubMed ID: 36277399
[TBL] [Abstract][Full Text] [Related]
25. Tau exon 10 alternative splicing and tauopathies.
Liu F; Gong CX
Mol Neurodegener; 2008 Jul; 3():8. PubMed ID: 18616804
[TBL] [Abstract][Full Text] [Related]
26. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
Yu Q; Guo J; Zhou J
J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
[TBL] [Abstract][Full Text] [Related]
27. Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy.
Espíndola SL; Damianich A; Alvarez RJ; Sartor M; Belforte JE; Ferrario JE; Gallo JM; Avale ME
Cell Rep; 2018 Apr; 23(3):709-715. PubMed ID: 29669277
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of casein kinase 1ε is involved in tau pathogenesis in Alzheimer's disease.
Chen C; Gu J; Basurto-Islas G; Jin N; Wu F; Gong CX; Iqbal K; Liu F
Sci Rep; 2017 Oct; 7(1):13478. PubMed ID: 29044200
[TBL] [Abstract][Full Text] [Related]
29. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
[TBL] [Abstract][Full Text] [Related]
30. SIRT1 regulates O-GlcNAcylation of tau through OGT.
Lu S; Yin X; Wang J; Gu Q; Huang Q; Jin N; Chu D; Xu Z; Liu F; Qian W
Aging (Albany NY); 2020 Apr; 12(8):7042-7055. PubMed ID: 32310828
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol Mitigates Hippocampal Tau Acetylation and Cognitive Deficit by Activation SIRT1 in Aged Rats following Anesthesia and Surgery.
Yan J; Luo A; Sun R; Tang X; Zhao Y; Zhang J; Zhou B; Zheng H; Yu H; Li S
Oxid Med Cell Longev; 2020; 2020():4635163. PubMed ID: 33381265
[TBL] [Abstract][Full Text] [Related]
32. Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons.
Lacovich V; Espindola SL; Alloatti M; Pozo Devoto V; Cromberg LE; Čarná ME; Forte G; Gallo JM; Bruno L; Stokin GB; Avale ME; Falzone TL
J Neurosci; 2017 Jan; 37(1):58-69. PubMed ID: 28053030
[TBL] [Abstract][Full Text] [Related]
33. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
34. Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.
Jin N; Yin X; Gu J; Zhang X; Shi J; Qian W; Ji Y; Cao M; Gu X; Ding F; Iqbal K; Gong CX; Liu F
J Biol Chem; 2015 Jun; 290(24):15219-37. PubMed ID: 25918155
[TBL] [Abstract][Full Text] [Related]
35. Developmental regulation of alternatively spliced isoforms of mRNA encoding MAP2 and tau in rat brain oligodendrocytes during culture maturation.
Richter-Landsberg C; Gorath M
J Neurosci Res; 1999 May; 56(3):259-70. PubMed ID: 10336255
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
Wang Y; Gao L; Tse SW; Andreadis A
Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
[TBL] [Abstract][Full Text] [Related]
37. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
[TBL] [Abstract][Full Text] [Related]
38. HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.
Kadri F; Pacifici M; Wilk A; Parker-Struckhoff A; Del Valle L; Hauser KF; Knapp PE; Parsons C; Jeansonne D; Lassak A; Peruzzi F
J Biol Chem; 2015 Dec; 290(52):30931-46. PubMed ID: 26534959
[TBL] [Abstract][Full Text] [Related]
39. Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer's disease.
Niblock M; Hortobágyi T; Troakes C; Al-Sarraj S; Spickett C; Jones R; Shaw CE; Gallo JM
Neurobiol Aging; 2016 Jan; 37():45-46. PubMed ID: 26507309
[TBL] [Abstract][Full Text] [Related]
40. Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway.
Chen KL; Yuan RY; Hu CJ; Hsu CY
Neurobiol Dis; 2010 Nov; 40(2):378-85. PubMed ID: 20615469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
